QuidelOrtho Past Earnings Performance
Past criteria checks 0/6
QuidelOrtho's earnings have been declining at an average annual rate of -48.8%, while the Medical Equipment industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 27.3% per year.
Key information
-48.8%
Earnings growth rate
-42.8%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 27.3% |
Return on equity | -58.6% |
Net Margin | -66.2% |
Last Earnings Update | 29 Sep 2024 |
Recent past performance updates
Recent updates
QuidelOrtho: Highly Levered With Questionable Growth
Nov 26Lacklustre Performance Is Driving QuidelOrtho Corporation's (NASDAQ:QDEL) Low P/S
Nov 17QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt
Sep 15QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry
Aug 09QuidelOrtho: Attractive Valuation Despite Weak Performance
Apr 13We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt
Apr 08QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues
Feb 15QuidelOrtho Corporation (NASDAQ:QDEL) Shares Could Be 38% Below Their Intrinsic Value Estimate
Mar 13QuidelOrtho Corporation Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Feb 18An Intrinsic Calculation For QuidelOrtho Corporation (NASDAQ:QDEL) Suggests It's 47% Undervalued
Nov 25Revenue & Expenses Breakdown
How QuidelOrtho makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
29 Sep 24 | 2,818 | -1,867 | 767 | 233 |
30 Jun 24 | 2,835 | -1,859 | 775 | 238 |
31 Mar 24 | 2,863 | -1,765 | 766 | 244 |
31 Dec 23 | 2,998 | -10 | 763 | 247 |
01 Oct 23 | 3,122 | 13 | 789 | 250 |
02 Jul 23 | 3,162 | 45 | 799 | 254 |
02 Apr 23 | 3,110 | 118 | 739 | 226 |
01 Jan 23 | 3,266 | 549 | 621 | 191 |
02 Oct 22 | 3,036 | 810 | 481 | 152 |
03 Jul 22 | 2,762 | 1,006 | 340 | 110 |
03 Apr 22 | 2,326 | 1,006 | 271 | 99 |
02 Jan 22 | 1,699 | 704 | 240 | 96 |
03 Oct 21 | 1,871 | 883 | 223 | 95 |
04 Jul 21 | 1,837 | 900 | 214 | 93 |
31 Mar 21 | 1,862 | 948 | 208 | 91 |
03 Jan 21 | 1,662 | 810 | 181 | 84 |
30 Sep 20 | 1,005 | 371 | 183 | 74 |
30 Jun 20 | 655 | 155 | 168 | 64 |
31 Mar 20 | 562 | 88 | 164 | 55 |
31 Dec 19 | 535 | 73 | 162 | 53 |
30 Sep 19 | 515 | 75 | 160 | 50 |
30 Jun 19 | 506 | 69 | 158 | 51 |
31 Mar 19 | 501 | 65 | 157 | 53 |
31 Dec 18 | 522 | 74 | 153 | 52 |
30 Sep 18 | 505 | 37 | 150 | 50 |
30 Jun 18 | 438 | 20 | 133 | 44 |
31 Mar 18 | 373 | 12 | 114 | 38 |
31 Dec 17 | 278 | -8 | 96 | 34 |
30 Sep 17 | 216 | -5 | 82 | 30 |
30 Jun 17 | 214 | 0 | 80 | 32 |
31 Mar 17 | 215 | 4 | 78 | 34 |
31 Dec 16 | 192 | -14 | 77 | 39 |
30 Sep 16 | 189 | -12 | 76 | 41 |
30 Jun 16 | 187 | -12 | 76 | 41 |
31 Mar 16 | 183 | -14 | 75 | 40 |
31 Dec 15 | 194 | -6 | 77 | 36 |
30 Sep 15 | 206 | 1 | 76 | 35 |
30 Jun 15 | 201 | -4 | 76 | 38 |
31 Mar 15 | 197 | -2 | 73 | 37 |
31 Dec 14 | 184 | -7 | 69 | 38 |
30 Sep 14 | 169 | -13 | 66 | 40 |
30 Jun 14 | 160 | -12 | 63 | 35 |
31 Mar 14 | 158 | -6 | 60 | 35 |
Quality Earnings: QDEL is currently unprofitable.
Growing Profit Margin: QDEL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: QDEL is unprofitable, and losses have increased over the past 5 years at a rate of 48.8% per year.
Accelerating Growth: Unable to compare QDEL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: QDEL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (15%).
Return on Equity
High ROE: QDEL has a negative Return on Equity (-58.57%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/05 04:02 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/09/29 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
QuidelOrtho Corporation is covered by 24 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Daniel Owczarski | Avondale Partners |
Ishan Majumdar | Baptista Research |
Mark Massaro | Canaccord Genuity |